Reports
Blood Testing Market Size & Share Global Analysis Report, 2026-2034
REPORT DETAILS
REPORT DETAILS
ABOUT THIS REPORT
Blood Testing Market Summary
The global blood testing market was valued at USD 106.72 billion in 2025. The market is expected to grow at a CAGR of 9.10% from 2026 to 2034. The increasing burden of chronic and infectious diseases, technological advancements in blood testing devices, and surging point-of-care (POC) testing centers are the major factors projected to drive the market development.
Market Statistics
Key Takeaways
- North America dominated with the largest share of 41.3% in 2025. This is due to the rising prevalence of chronic diseases such as diabetes, cardiovascular disease, and cancer.
- Asia Pacific is projected to account for a significant share of 29.8%. This is owing to increasing investment in the healthcare sector.
- The blood glucose test is expected to account for the highest growth rate of 10.4% in the forecast period due to the increasing diabetic population.
- The reagents & kits segment is anticipated to dominate the market with a 63.7% share. Increased blood transfusion procedures contribute to the segment’s leading share.
- The automated segment is projected to witness the fastest growth at a 9.8% CAGR. Increased efficiency and technological advancements drive the segment’s growth
Note: Figures and projections outlined in this report are the result of Polaris Market Research’s proprietary analytical processes, grounded in the latest available datasets and market observations.
Industry Dynamics
- The increasing prevalence of chronic and infectious diseases is fueling the growth.
- The surging demand for point-of-care (POC) testing centers is driving the industry growth.
- Technological advancement is driving the growth.
- The risk of inaccurate results due to sample contamination or improper handling, which can lead to misdiagnosis and reduced trust in testing accuracy is limiting the adoption.
Impact of AI on Industry
- AI algorithms analyze blood test data rapidly, reducing turnaround time and improving diagnostic precision.
- AI helps forecast disease risks based on historical blood test data, supporting preventive care strategies.
- AI integrates blood test results with patient histories to recommend tailored treatment options
To Understand More About this Research: Download Sample Report
For instance, as per International Diabetes Federation, India has the highest number of people with diabetes in the world, with about 77 million people living with diabetes, and is projected to reach a value of 134 million by 2045. The increasing number of chronic diseases in India and other countries has necessitated the testing to detect the disease.
A blood test is a medical procedure in which a healthcare professional draws blood samples from a patient's vein using a needle, syringe, or another device. The blood sample is then sent to a laboratory for analysis to determine various aspects of a patient's health.
Blood tests are used for various purposes, including diagnosing diseases and medical conditions, monitoring the effectiveness of treatments, and evaluating overall health. Common blood tests include a complete blood count (CBC), which measures different types of blood cells and their quantities; a blood chemistry test, which evaluates the levels of various chemicals and substances in the blood; and blood glucose tests, which measure the amount of glucose (sugar) in the blood and are commonly used to diagnose and manage diabetes.
The blood glucose test measures the amount of glucose (sugar) in the blood and is commonly used to diagnose and manage diabetes. Similarly, the liver function test evaluates the functioning of the liver by measuring the levels of various enzymes and proteins in the blood.
Higher cost of these testing devices, errors associated with the testing process, and stringent regulatory approval process are some factors expected to hamper the market growth. The market is subject to strict regulations and oversight from government agencies, such as the U.S. Food and Drug Administration (FDA), which can create barriers to entry for new market players and increase the costs and time required for product development and approval.
Blood Testing vs Other Diagnostic Methods
| Factors | Blood Tests | Imaging and Biopsy Techniques |
| Type of procedure | Minimally invasive | Potentially invasive or equipment-dependent |
| Speed | Potential for quick results | Can take more time |
| Use for disease monitoring | Useful for regular monitoring | Useful for analyzing structures and tissues |
| Cost | Less costly | More costly |
| Availability | Readily accessible | Limited availability in certain areas |
| Uses | Analysis of biomarkers and chemicals | Imaging and analysis of organs and tissues |
Know more about this report: Download Sample Report
Industry Dynamics
Growth Drivers
The increasing prevalence of chronic and infectious diseases are primary growth factor for the blood testing market. Chronic diseases such as diabetes, cancer, and cardiovascular disease are among the leading causes of death worldwide, and the incidence of these diseases is expected to increase as the population ages. Infectious diseases such as HIV, hepatitis, and tuberculosis remain significant public health threats, particularly in low- and middle-income countries.
Technological advancements in the testing devices drive growth in the market by increasing the speed, accuracy, and convenience of testing and expanding the range of tests that can be performed. Companies that can provide innovative, reliable, and cost-effective testing solutions incorporating these technological advancements will likely succeed in this dynamic market.
The surging demand for point-of-care (POC) testing centers is a significant growth factor for the blood testing market. POC testing refers to diagnostic tests in non-laboratory settings, such as clinics, pharmacies, and homes. POC testing offers several benefits over traditional laboratory testing, including faster results, greater convenience, and lower costs.
The rise in home healthcare service provision and the use of telemedicine platforms is greatly boosting the uptake of at-home blood testing kits across various countries worldwide. Patients are now using self-testing technology to monitor their blood sugar levels, cholesterol, hormonal balance, vitamin deficiencies, and overall well-being without having to visit hospitals and laboratories regularly. This kind of testing technology makes it more convenient, fast, and accessible for elderly people, patients suffering from long-term illnesses, and those who live in distant locations. The use of telehealth and health applications enables patients to send their results to health practitioners online for further diagnosis and treatment. Moreover, rising knowledge about preventive healthcare and personalized health management is also promoting the uptake of self-testing technologies in global healthcare markets.
Report Segmentation
The market is primarily segmented based on test, product, method, end-use, and region
| By Test | By Product | By Method | By End-Use | By Region |
|
|
|
|
|
Know more about this report: Download Sample Report
The blood glucose test is expected to account for the fastest growth rate in the forecast period.
The segment is anticipated to witness the fastest growth owing to various factors, such as the increasing diabetic population across the region. The global prevalence of diabetes is increasing, particularly in developing countries. Blood glucose testing is essential to diabetes management, driving demand for blood glucose testing devices and products. Healthcare providers and patients are increasingly aware of the importance of monitoring blood glucose levels for diabetes management drives the demand for blood glucose testing devices and products.
Reagents & Kits are anticipated to dominate the market in the forecast period.
The reagents and kits segment of the market is experiencing growth due to increased blood transfusion procedures. Blood transfusion is a common medical procedure involving transferring blood or blood products from one person to another. It treats various conditions, including anemia, bleeding disorders, and cancer. The demand for blood transfusions is increasing due to a growing number of surgical procedures, cancer treatments, and other medical interventions that require blood transfusions. This is driving demand for reagents and kits used in blood typing and screening, as well as in blood collection and processing.
The automated segment is the fastest-growing segment in the market.
The automated testing method is a rapidly growing segment in the market, driven by increased efficiency, technological advancements, and increasing demand. Automation of testing processes reduces human error and increases efficiency. It allows for faster turnaround times for test results and reduces the need for manual labor, which can be time-consuming and costly. The systems can help healthcare providers reduce costs by minimizing the need for manual labor and reducing the risk of errors. Additionally, these systems help reduce the need for repeat testing, which can be costly and time-consuming.
Diagnostic centers are expected to account for the fastest growth rate in the forecast period.
The demand for diagnostic services is increasing due to a growing aging population, increasing prevalence of chronic diseases, and the need for regular health screenings. Diagnostic centers offer various services, including blood testing, that help patients and healthcare providers identify and manage health conditions. There is growing awareness among patients and healthcare providers about the importance of preventive healthcare, including regular health screenings and early detection of health conditions. Diagnostic centers are key in providing these services, including testing, to help identify potential health issues.
North America region accounted for largest share.
North America has a high prevalence of chronic diseases such as diabetes, cardiovascular disease, and cancer. The testing plays a crucial role in diagnosing and managing these conditions, driving demand for testing services in the region. The North American region is home to many leading companies and research institutions operating technological advancements in testing. It includes the development of more accurate and efficient devices and the use of artificial intelligence and machine learning to improve the accuracy of blood testing results. The healthcare infrastructure in North America is well-developed, with many hospitals, clinics, and diagnostic centers offering testing services. It, coupled with high healthcare spending, drives the region's demand for blood testing services.
Asia Pacific is expected to witness significant growth.
The Asia Pacific is expected to witness significant growth during the forecast period due to rising investment in the healthcare sector. Major developing countries such as India, Vietnam, and Bangladesh are investing in healthcare sector to improve the healthcare infrastructure. This rise in investment in the sector increases the number of hospitals and diagnostics centers. This rise in the number fuels the demand for the blood testing kits in the region. Moreover, rising prevalence of chronic disease is fueling the demand for the accurate diagnostic kits to detect disease at early stage. This is fueling the demand for the blood testing kits, thereby fueling the growth in Asia Pacific.
Competitive Insight
The blood testing market is highly competitive, with key players focusing on developing advanced diagnostic tests, automation solutions, and point-of-care testing products. Large companies have been making substantial investments in AI-enabled diagnostics, biomarkers, and lab equipment to improve the testing process in terms of efficiency, accuracy, and speed. Moreover, mergers and acquisitions, partnerships, and new product launches have become part of the business strategy in the blood testing industry as companies try to expand their presence globally. Another important factor contributing to the growth of the blood testing market is the increased need for personalized medicine and home blood tests, among other trends.
Some of the prominent key players operating in the blood testing market space includes:
- Diagnostics
- Becton Dickinson and Company
- BD.
- Biomerica Inc.
- bioMérieux SA
- Roche Diagnostics
- Siemens AG
- Thermo Fisher Scientific Inc.
- Trinity Biotech PLC
- Quest Diagnostics
- Siemens Healthineers
- F. Hoffmann-La Roche AG
- Danaher Corporation
- Bruker Corporation
- Cepheid
Recent Developments
-
May 2026: Roche, in partnership with Eli Lilly, obtained the CE mark for its Elecsys pTau217 blood test in Europe. This test is designed to diagnose early-stage Alzheimer’s disease pathology by measuring the levels of phosphorylated Tau 217 in the blood. (source: roche.com)
-
May 2026: DELFI Diagnostics announced it will present the first clinical utility evidence for its cfDNA fragmentomics-based blood test designed for lung cancer screening at the American Thoracic Society (ATS) 2026 International Conference. This real-world data demonstrates highly accessible early detection for at-risk and underserved populations. (source: prnewswire.com).
Blood Testing Market Report Scope
| Report Attributes | Details |
| Market size value in 2025 | USD 106.72 Billion |
| Market size value in 2026 | USD 109.34 Billion |
| Revenue forecast in 2034 | USD 233.74 Billion |
| CAGR | 9.1% from 2026 - 2034 |
| Base year | 2025 |
| Historical data | 2021 - 2024 |
| Forecast period | 2026 - 2034 |
| Quantitative units | Revenue in USD Billion and CAGR from 2026 to 2034 |
| Segments covered | By Test, By Product, By Method, By End-Use, By Region |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Key companies | Abbott Diagnostics, Becton Dickinson and Company, BD, Biomerica, Inc., bioMérieux SA, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific Inc., Trinity Biotech PLC, Quest Diagnostics, Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Bruker Corporation, Cepheid |
FAQ's
Key companies in the blood testing market are Abbott Diagnostics, Becton Dickinson and Company, BD., Biomerica, Inc., bioMérieux SA, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific Inc.
The global blood testing market expected to grow at a CAGR of 9.1% in the forecast period.
The blood testing market report covering key segments are test, product, method, end-use, and region.
Key driving factors in blood testing market are implementation of favorable government initiatives & external funding for R&D activities.
The blood testing market size is expected to reach USD 233.74 Billion by 2034.
Download Sample Report of blood testing market
Please fill out the form to request a customized copy of the research report.
